130 related articles for article (PubMed ID: 36315051)
1. A Lock-and-Kill Anticancer Photoactivated Chemotherapy Agent
van Geest EP; Götzfried SK; Klein DM; Salitra N; Popal S; Husiev Y; Van der Griend CJ; Zhou X; Siegler MA; Schneider GF; Bonnet S
Photochem Photobiol; 2023 Mar; 99(2):777-786. PubMed ID: 36315051
[TBL] [Abstract][Full Text] [Related]
2. Ruthenium-based PACT agents based on bisquinoline chelates: synthesis, photochemistry, and cytotoxicity.
Busemann A; Flaspohler I; Zhou XQ; Schmidt C; Goetzfried SK; van Rixel VHS; Ott I; Siegler MA; Bonnet S
J Biol Inorg Chem; 2021 Sep; 26(6):667-674. PubMed ID: 34378103
[TBL] [Abstract][Full Text] [Related]
3. d- Versus l-Glucose Conjugation: Mitochondrial Targeting of a Light-Activated Dual-Mode-of-Action Ruthenium-Based Anticancer Prodrug.
Lameijer LN; Hopkins SL; Brevé TG; Askes SH; Bonnet S
Chemistry; 2016 Dec; 22(51):18484-18491. PubMed ID: 27859843
[TBL] [Abstract][Full Text] [Related]
4. Ruthenium-Based Photoactivated Chemotherapy.
Bonnet S
J Am Chem Soc; 2023 Nov; 145(43):23397-23415. PubMed ID: 37846939
[TBL] [Abstract][Full Text] [Related]
5. Preparation, stability, and photoreactivity of thiolato ruthenium polypyridyl complexes: Can cysteine derivatives protect ruthenium-based anticancer complexes?
van Rixel VH; Busemann A; Göttle AJ; Bonnet S
J Inorg Biochem; 2015 Sep; 150():174-81. PubMed ID: 26187140
[TBL] [Abstract][Full Text] [Related]
6. Cyclic Ruthenium-Peptide Conjugates as Integrin-Targeting Phototherapeutic Prodrugs for the Treatment of Brain Tumors.
Zhang L; Wang P; Zhou XQ; Bretin L; Zeng X; Husiev Y; Polanco EA; Zhao G; Wijaya LS; Biver T; Le Dévédec SE; Sun W; Bonnet S
J Am Chem Soc; 2023 Jul; 145(27):14963-14980. PubMed ID: 37379365
[TBL] [Abstract][Full Text] [Related]
7. Light-activated ruthenium (II)-bicalutamide prodrugs for prostate cancer.
Zhao J; Liu N; Sun S; Gou S; Wang X; Wang Z; Li X; Zhang W
J Inorg Biochem; 2019 Jul; 196():110684. PubMed ID: 31054419
[TBL] [Abstract][Full Text] [Related]
8. Steric hindrance, ligand ejection and associated photocytotoxic properties of ruthenium(II) polypyridyl complexes.
Herrera-Ramírez P; Berger SA; Josa D; Aguilà D; Caballero AB; Fontova P; Soto-Cerrato V; Martínez M; Gamez P
J Biol Inorg Chem; 2023 Jun; 28(4):403-420. PubMed ID: 37059909
[TBL] [Abstract][Full Text] [Related]
9. Strong Influence of Ancillary Ligands Containing Benzothiazole or Benzimidazole Rings on Cytotoxicity and Photoactivation of Ru(II) Arene Complexes.
Lari M; Martínez-Alonso M; Busto N; Manzano BR; Rodríguez AM; Acuña MI; Domínguez F; Albasanz JL; Leal JM; Espino G; García B
Inorg Chem; 2018 Nov; 57(22):14322-14336. PubMed ID: 30379535
[TBL] [Abstract][Full Text] [Related]
10. A bis(dipyridophenazine)(2-(2-pyridyl)pyrimidine-4-carboxylic acid)ruthenium(II) complex with anticancer action upon photodeprotection.
Joshi T; Pierroz V; Mari C; Gemperle L; Ferrari S; Gasser G
Angew Chem Int Ed Engl; 2014 Mar; 53(11):2960-3. PubMed ID: 24500767
[TBL] [Abstract][Full Text] [Related]
11. Towards Light-Activated Ruthenium-Arene (RAPTA-Type) Prodrug Candidates.
Renfrew AK; Karges J; Scopelliti R; Bobbink FD; Nowak-Sliwinska P; Gasser G; Dyson PJ
Chembiochem; 2019 Nov; 20(22):2876-2882. PubMed ID: 31102568
[TBL] [Abstract][Full Text] [Related]
12. Photosubstitution in a trisheteroleptic ruthenium complex inhibits conjunctival melanoma growth in a zebrafish orthotopic xenograft model.
Chen Q; Cuello-Garibo JA; Bretin L; Zhang L; Ramu V; Aydar Y; Batsiun Y; Bronkhorst S; Husiev Y; Beztsinna N; Chen L; Zhou XQ; Schmidt C; Ott I; Jager MJ; Brouwer AM; Snaar-Jagalska BE; Bonnet S
Chem Sci; 2022 Jun; 13(23):6899-6919. PubMed ID: 35774173
[No Abstract] [Full Text] [Related]
13. To cage or to be caged? The cytotoxic species in ruthenium-based photoactivated chemotherapy is not always the metal.
Cuello-Garibo JA; Meijer MS; Bonnet S
Chem Commun (Camb); 2017 Jun; 53(50):6768-6771. PubMed ID: 28597879
[TBL] [Abstract][Full Text] [Related]
14. Pyrazole appended quinoline-BODIPY based arene ruthenium complexes: their anticancer activity and potential applications in cellular imaging.
Paitandi RP; Sharma V; Singh VD; Dwivedi BK; Mobin SM; Pandey DS
Dalton Trans; 2018 Dec; 47(48):17500-17514. PubMed ID: 30507985
[TBL] [Abstract][Full Text] [Related]
15. Photolabile ruthenium complexes to cage and release a highly cytotoxic anticancer agent.
Wei J; Renfrew AK
J Inorg Biochem; 2018 Feb; 179():146-153. PubMed ID: 29180165
[TBL] [Abstract][Full Text] [Related]
16. Ruthenium Complexes are pH-Activated Metallo Prodrugs (pHAMPs) with Light-Triggered Selective Toxicity Toward Cancer Cells.
Qu F; Park S; Martinez K; Gray JL; Thowfeik FS; Lundeen JA; Kuhn AE; Charboneau DJ; Gerlach DL; Lockart MM; Law JA; Jernigan KL; Chambers N; Zeller M; Piro NA; Kassel WS; Schmehl RH; Paul JJ; Merino EJ; Kim Y; Papish ET
Inorg Chem; 2017 Jul; 56(13):7519-7532. PubMed ID: 28636344
[TBL] [Abstract][Full Text] [Related]
17. A Ru-anthraquinone dyad with triple functions of PACT, photoredox catalysis and PDT upon red light irradiation.
Zhang C; Guo X; Da X; Wang Z; Wang X; Zhou Q
Dalton Trans; 2021 Aug; 50(31):10845-10852. PubMed ID: 34296720
[TBL] [Abstract][Full Text] [Related]
18. A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies.
Tian N; Feng Y; Sun W; Lu J; Lu S; Yao Y; Li C; Wang X; Zhou Q
Dalton Trans; 2019 May; 48(19):6492-6500. PubMed ID: 30994660
[TBL] [Abstract][Full Text] [Related]
19. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.
Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ
J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123
[TBL] [Abstract][Full Text] [Related]
20. Kinetically labile ruthenium(II) complexes of terpyridines and saccharin: effect of substituents on photoactivity, solvation kinetics, and photocytotoxicity.
Kumar P; Singh P; Saren S; Pakira S; Sivakumar S; Patra AK
Dalton Trans; 2021 Jun; 50(23):8196-8217. PubMed ID: 34031678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
